Nicolas Ansermot

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


53 publications

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2002 |
2023
 
Prescription d’antipsychotiques chez les adultes : à quoi faut-il être attentif ? [Antipsychotic prescribing in adults : what to watch out for ?]
Grandjean C., Vandenberghe F., Dubath C., Sibailly G., Ansermot N., Crettol Wavre S., Eap C.B., 2023/09/20. Revue medicale suisse, 19 (842) pp. 1707-1712. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A5F7D63D1926]
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.
Sjaarda J., Delacrétaz A., Dubath C., Laaboub N., Piras M., Grosu C., Vandenberghe F., Crettol S., Ansermot N., Gamma F. et al., 2023/06. Molecular psychiatry, 28 (6) pp. 2320-2327. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC34831410AA]
2022
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.
Perry B.I., Vandenberghe F., Garrido-Torres N., Osimo E.F., Piras M., Vazquez-Bourgon J., Upthegrove R., Grosu C., De La Foz V.O., Jones P.B. et al., 2022/11. The Lancet regional health. Europe, 22 p. 100493. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A56B7AE8F057]
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
Laaboub N., Dubath C., Ranjbar S., Sibailly G., Grosu C., Piras M., Délessert D., Richard-Lepouriel H., Ansermot N., Crettol S. et al., 2022/05/17. BMC psychiatry, 22 (1) p. 342. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E9824076089]
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.
Schoretsanitis G., Dubath C., Grosu C., Piras M., Laaboub N., Ranjbar S., Ansermot N., Crettol S., Vandenberghe F., Gamma F. et al., 2022/04. Basic & clinical pharmacology & toxicology, 130 (4) pp. 531-541. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_995572119F81]
Psychotropic Drug Prescription in Children and Adolescents: Approved Medications in European Countries and the United States.
Smogur M., Onesanu A., Plessen K.J., Eap C.B., Ansermot N., 2022/03. Journal of child and adolescent psychopharmacology, 32 (2) pp. 80-88. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9623F2827944]
Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity.
Guinchat V., Ansermot N., Ing Lorenzini K., Politis D., Daali Y., Eap C.B., Crettol S., 2022. Frontiers in psychiatry, 13 p. 910684. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8AD25DFBCE50]
2021
Gabapentinoïdes : mésusages et addictions [Gabapentinoids : misuses and addictions]
Grandjean C., Crettol Wavre S., Khazaal Y., Sanchis Zozaya J., Ansermot N., Vandenberghe F., Sibailly G., Eap C.B., 2021/12/15. Revue medicale suisse, 17 (763) pp. 2206-2208. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CADF3E9C3F84]
 
Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies.
Petrovic D., Pruijm M., Ponte B., Dhayat N.A., Ackermann D., Ehret G., Ansermot N., Vogt B., Martin P.Y., Stringhini S. et al., 2021/12. Mayo Clinic proceedings, 96 (12) pp. 3071-3085. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_96BE60BE6909]
Recommandations de prise en charge des mésusages et addictions aux benzodiazepines [Recommendations for management of misuses and addictions to benzodiazepines]
Grandjean C., Crettol Wavre S., Khazaal Y., Sanchis Zozaya J., Ansermot N., Vandenberghe F., Sibailly G., Eap C.B., 2021/10/13. Revue medicale suisse, 17 (754) pp. 1754-1759. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5EEA6C9D3688]
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
Eap C.B., Gründer G., Baumann P., Ansermot N., Conca A., Corruble E., Crettol S., Dahl M.L., de Leon J., Greiner C. et al., 2021/10. The world journal of biological psychiatry, 22 (8) pp. 561-628. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6FD14CC75A02]
Traitement de l’insomnie, par quoi commencer ? [Treatment of insomnia, with what to start ?]
Grandjean C., Crettol Wavre S., Ansermot N., Vandenberghe F., Sibailly G., Eap C.B., 2021/05/05. Revue medicale suisse, 17 (737) pp. 890-897. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_44F7FFE9FAFC]
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort.
Laaboub N., Gholam M., Sibailly G., Sjaarda J., Delacrétaz A., Dubath C., Grosu C., Piras M., Ansermot N., Crettol S. et al., 2021. Frontiers in psychiatry, 12 p. 756403. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C84BB0F598EF]
2020
Agitation aiguë chez l’adulte : proposition d’un algorithme de traitement psychopharmacologique [Rapid tranquilisation in adults : algorithm proposed for psychopharmacological treatment]
Crettol Wavre S., Ansermot N., Sibailly G., Vandenberghe F., Grandjean C., Teixeira Robalo B., Fassassi Gallo S., Thonney J., Solida-Tozzi A., Conus P. et al., 2020/09/23. Revue medicale suisse, 16 (707) pp. 1751-1755. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7B77DD272619]
2019
Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients.
Ansermot N., Bochatay M., Schläpfer J., Gholam M., Gonthier A., Conus P., Eap C.B., 2019. Therapeutic advances in psychopharmacology, 9 p. 2045125319891386. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_29A9AAC54485]
2018
Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
Delacrétaz Aurélie, Vandenberghe Frederik, Glatard Anaïs, Levier Axel, Dubath Céline, Ansermot Nicolas, Crettol Séverine, Gholam-Rezaee Mehdi, Guessous Idris, Bochud Murielle et al., 2018/11/09. Frontiers in Psychiatry, 9.
[URN][DOI][WoS][Pmid][serval:BIB_EFD90D5BB70B]
 
Associations of Urinary Caffeine and Caffeine Metabolites With Arterial Stiffness in a Large Population-Based Study.
Ponte B., Pruijm M., Ackermann D., Ehret G., Ansermot N., Staessen J.A., Vogt B., Pechère-Bertschi A., Burnier M., Martin P.Y. et al., 2018/05. Mayo Clinic proceedings, 93 (5) pp. 586-596. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9160FD0FD82A]
Psychotropic Drug Prescription in Adolescents: A Retrospective Study in a Swiss Psychiatric University Hospital.
Ansermot N., Jordanov V., Smogur M., Holzer L., Eap C.B., 2018/04. Journal of child and adolescent psychopharmacology, 28 (3) pp. 192-204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_112AFACDE6F0]
2017
 
Simultaneous determination of selective serotonin reuptake inhibitors and their main metabolites in human breast milk by liquid chromatography-electrospray mass spectrometry.
Weisskopf E., Panchaud A., Nguyen K.A., Grosjean D., Hascoët J.M., Csajka C., Eap C.B., Ansermot N., collaborators of the SSRI-Breast Milk study, 2017/07/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1057 pp. 101-109. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EA86621FAFDC]
 
Étude rétrospective sur le suivi électrocardiographique (ECG) des patients hospitalisés en psychiatrie adulte
Ansermot N., Bochatay M., Schläpfer J., Gholamrezaee M., Gonthier A., Conus P., Eap C., 2017/03., 20e journées franco-suisses de pharmacie hospitalière pp. e15-e16 dans Le Pharmacien Hospitalier et Clinicien, Elsevier BV.
[DOI][serval:BIB_B97F5A878EBF]
2016
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers.
Vandenberghe F., Saigí-Morgui N., Delacrétaz A., Quteineh L., Crettol S., Ansermot N., Gholam-Rezaee M., von Gunten A., Conus P., Eap C.B., 2016/12. Pharmacogenetics and genomics, 26 (12) pp. 547-557. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BFD29890FF60]
 
Stereoselective determination of citalopram and desmethylcitalopram in human plasma and breast milk by liquid chromatography tandem mass spectrometry.
Weisskopf E., Panchaud A., Nguyen K.A., Grosjean D., Hascoët J.M., Csajka C., Eap C.B., Ansermot N., collaborators of the SSRI-Breast Milk study, 2016/11/30. Journal of pharmaceutical and biomedical analysis, 131 pp. 233-245. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B83BFE02B0D1]
Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general population.
Petrovic D., Estoppey Younes S., Pruijm M., Ponte B., Ackermann D., Ehret G., Ansermot N., Mohaupt M., Paccaud F., Vogt B. et al., 2016. Nutrition & metabolism, 13 p. 81. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F638EC8299DC]
2015
 
1C.06: Ambulatory pulse pressure is negatively associated with excretions of urinary caffeine and its metabolites
Guessous I., Pruijm M., Ponte B., Ehret G., Ansermot N., Vuistiner P., Staessen J.A., Gu Y.M., Paccaud F., Mohaupt M.G. et al., 2015/06., ESH 2015: 25th European meeting on hypertension and cardiovascular protection, 12-15 June 2015, Milan (Italy) pp. e10-e11 dans J Hypertension. Peer-reviewed.
[DOI][Pmid][serval:BIB_408916E57FC5]
 
Severe manic episode associated with tramadol in a patient with recurrent depressive disorder.
Ansermot N., Chocron O., Herrera F., Eap C.B., 2015/04. Journal of clinical psychopharmacology, 35 (2) pp. 203-204. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_396C716C67CD]
 
Adolescent psychotropic drug use in a Swiss psychiatric university hospital: retrospective studies in 2008 and 2014
Jordanov V., Smogur M., Holzer L., Eap C., Ansermot N., 2015. dans GSASA-Kongress 2015.
[serval:BIB_78ADB907CD2E]
 
Associations of ambulatory blood pressure with urinary caffeine and caffeine metabolite excretions.
Guessous I., Pruijm M., Ponte B., Ackermann D., Ehret G., Ansermot N., Vuistiner P., Staessen J., Gu Y., Paccaud F. et al., 2015. Hypertension, 65 (3) pp. 691-696. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C5A6ADCBDFAD]
2014
Can Valproic Acid be an Inducer of Clozapine Metabolism?
Diaz F.J., Eap C.B., Ansermot N., Crettol S., Spina E., de Leon J., 2014. Pharmacopsychiatry, 47 (3) pp. 89-96. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B56EBAE8B792]
 
Prescription de médicaments psychotropes chez des adolescents hospitalisés en milieu psychiatrique
Ansermot N, Smogur M, Holzer L, Eap Chin B, 2014. dans 2ème congrès suisse des pharmaciens.
[serval:BIB_EA57A5110A2A]
 
Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring.
Gradinaru J., Vullioud A., Eap C.B., Ansermot N., 2014. Journal of Pharmaceutical and Biomedical Analysis, 88 pp. 36-44. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5D0365228365]
 
Serotonin toxicity after addition of mirtazapine to escitalopram.
Ansermot N., Hodel P.F., Eap C.B., 2014. Journal of Clinical Psychopharmacology, 34 (4) pp. 540-541. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7E75CEBD3530]
2013
 
Buprenorphine and norbuprenorphine quantification in human plasma by simple protein precipitation and ultra-high performance liquid chromatography tandem mass spectrometry.
Lüthi G., Blangy V., Eap C.B., Ansermot N., 2013. Journal of Pharmaceutical and Biomedical Analysis, 77 pp. 1-8. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F8692423950C]
 
Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring.
Ansermot N., Brawand-Amey M., Kottelat A., Eap C.B., 2013. Journal of Chromatography. A, 1292 pp. 160-172. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BD61DC449C3A]
2012
 
Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC-MS to UPLC-MS/MS.
Noetzli M., Ansermot N., Dobrinas M., Eap C.B., 2012. Journal of Pharmaceutical and Biomedical Analysis, 64-65 pp. 16-25. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_729D59AF62E3]
 
Simultaneous quantification of selective serotonin reuptake inhibitors and metabolites in human plasma by liquid chromatography-electrospray mass spectrometry for therapeutic drug monitoring.
Ansermot N., Brawand-Amey M., Eap C.B., 2012. Journal of Chromatography. B, Analytical Technologies In the Biomedical and Life Sciences, 885-886 pp. 117-130. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A240259C3DE5]
2011
Addition of aripiprazole to the clozapine may be useful in reducing anxiety in treatment-resistant schizophrenia.
Chanachev A., Ansermot N., Crettol Wavre S., Nowotka U., Stamatopoulou M.E., Conus P., Eap C.B., 2011. Case Reports In Psychiatry, 2011 p. 846489. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_70D83905314A]
 
Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation.
Dobrinas M., Choong E., Noetzli M., Cornuz J., Ansermot N., Eap C.B., 2011. Journal of Chromatography. B, Analytical Technologies In the Biomedical and Life Sciences, 879 (30) pp. 3574-3582. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_36445F679F00]
 
Simultaneous determination of antidementia drugs by HPLC-MS: validation data of the method and plasma level determinations in 300 patients
Noetzli M., Choong E., Ansermot N., Eap C.B., 2011. p. 501 dans 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Therapeutic Drug Monitoring. Peer-reviewed.
[WoS][serval:BIB_76D89205506F]
 
Simultaneous determination of antidementia drugs in human plasma for therapeutic drug monitoring.
Noetzli M., Choong E., Ansermot N., Eap C.B., 2011. Therapeutic Drug Monitoring, 33 (2) pp. 227-238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_982CF39955B2]
2010
 
Does Methadone Prolong QTc Intervals by Depleting Testosterone Levels?—Reply
Ansermot Nicolas, Albayrak Oezguer, Schlaepfer Juerg, Wavre Crettol Séverine, Croquette-Krokar Marina, Bourquin Michel, Deglon J.J., Faouzi M., Rey F., Scherbaum N. et al., 2010/08/09. Archives of Internal Medicine, 170 (15) p. 1407. Peer-reviewed.
[DOI][WoS][serval:BIB_C13BF53FCF4F]
 
Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc interval.
Ansermot N., Albayrak O., Schläpfer J., Crettol S., Croquette-Krokar M., Bourquin M., Déglon J.J., Faouzi M., Scherbaum N., Eap C.B., 2010/03/22. Archives of internal medicine, 170 (6) pp. 529-536. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2447D2DCD9A6]
2009
 
The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test.
Oneda B., Crettol S., Jaquenoud Sirot E., Bochud M., Ansermot N., Eap C.B., 2009/11. Pharmacogenetics and genomics, 19 (11) pp. 877-883. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_078310C1D51D]
 
ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
Jaquenoud Sirot E., Knezevic B., Morena G.P., Harenberg S., Oneda B., Crettol S., Ansermot N., Baumann P., Eap C.B., 2009/08. Journal of clinical psychopharmacology, 29 (4) pp. 319-326. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F54C2F3BEB3]
 
Un regard sur la schizophrénie
Bertholet Léa, Do Kim Q., Schenk Françoise, Ansermot Nicolas, Eap Chin B., 2009. Actualités psychologiques 22 pp. 77-106.
[serval:BIB_3F4C90885A67]
 
Validation and long-term evaluation of a modified on-line chiral analytical method for therapeutic drug monitoring of (R,S)-methadone in clinical samples.
Ansermot N., Rudaz S., Brawand-Amey M., Fleury-Souverain S., Veuthey J.L., Eap C.B., 2009. Journal of Chromatography. B, 877 (23) pp. 2301-2307. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0D3A9161914E]
2008
 
Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography–electrospray mass spectrometry with the enzyme multiplied immunoassay technique
Ansermot Nicolas, Fathi Marc, Veuthey Jean-Luc, Desmeules Jules, Rudaz Serge, Hochstrasser Denis, 2008/07. Clinical Biochemistry, 41 (10-11) pp. 910-913.
[DOI][WoS][Pmid][serval:BIB_D2B75238C82B]
 
Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography–electrospray mass spectrometry
Ansermot Nicolas, Fathi Marc, Veuthey Jean-Luc, Desmeules Jules, Rudaz Serge, Hochstrasser Denis, 2008/06. Clinical Biochemistry, 41 (9) pp. 728-735.
[DOI][WoS][Pmid][serval:BIB_9A753F8E0892]
 
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers.
Ansermot N., Rebsamen M., Chabert J., Fathi M., Gex-Fabry M., Daali Y., Besson M., Rossier M., Rudaz S., Hochstrasser D. et al., 2008/04. Drug metabolism letters, 2 (2) pp. 76-82. Peer-reviewed.
[Pmid][serval:BIB_579EC50242B5]
 
Dosage de la ciclosporine dans les cellules mononucléaires du sang périphérique
Ansermot N., Fathi M., Veuthey JL., Desmeules J., Hochstrasser D., Rudaz S., 2008. Pipette – Swiss Laboratory Medicine 6 pp. 15-16.
[serval:BIB_2C23F9B6A2CD]
 
Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Fontana Massimiliano, Aubert John-David, Ansermot Nicolas, Fathi Marc, Pascual Manuel, Eap Chin-Bin, 2008. Pharmacogenetics and Genomics, 18 (4) pp. 307-315. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B47AB7C75055]
2007
 
Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach
ANSERMOT N, FATHI M, VEUTHEY J, DESMEULES J, HOCHSTRASSER D, RUDAZ S, 2007/09/15. Journal of Chromatography B, 857 (1) pp. 92-99.
[DOI][WoS][Pmid][serval:BIB_60E98582764D]
2006
 
Influence of MDR1 genetic polymorphisms on intralymphocyte concentrations of cyclosporine A in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Aubert John-David, Fontana Massimiliano, Ansermot Nicolas, Fathi Marc, Brocard Murielle, Pascual Manuel, Eap Chin-Bin, 2006. p. 197 dans NA, Transplantation. Peer-reviewed.
[serval:BIB_2593E2C77971]
2002
 
Détermination de la fiabilité des flacons compte-gouttes pour l'administration des solutions orales: mise au point d'un test standardisé et application à des spécialités pédiatriques
Ansermot Nicolas, Griffiths William, Bonnabry Pascal, 2002. Le pharmacien hospitalier, 37 (151) pp. 233-237.
[serval:BIB_91042DA6140C]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University